Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Adenomatous Polyposis Coli × Docosahexaenoic Acids × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polyps 1 Melanoma 1 Lymphoma, Follicular 1 Huntington Disease 1 Carcinoma, Non-Small-Cell Lung 1 Adenomatous Polyposis Coli 1

Interventions

Sulindac 2 Eflornithine 2 Celecoxib 2 Docosahexaenoic Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03806426 2024-04-25

Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis

S.L.A. Pharma AG

Phase 3 Active not recruiting

Gastrointestinal

Adenomatous Polyposis Coli, Polyps

Data powered by HemOnc (CC BY 4.0) Colophon ⚡